NBP NBP
Company Profile ↓Company Overview
NBP (NBP) is a publicly traded company listed on with a market capitalization of $444.01M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -44.03% |
| 6 Months: | -52.87% |
| 3 Months: | -31.09% |
| 1 Month: | -18.81% |
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)41.51 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 75.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | 13.37M | 5.27M | 7.11M | 8.99M | 72.90M |
| Operating Income | -13.37M | -5.27M | -7.11M | -8.99M | -72.90M |
| EBITDA | -13.16M | -5.27M | -7.11M | -8.77M | -72.68M |
| Interest Expense | - | - | - | - | - |
| Pretax Income | -10.84M | -3.15M | -5.50M | -6.83M | -72.86M |
| Tax Provision | 0 | 0 | 0 | 0 | 0 |
| Net Income | -9.06M | -3.15M | -5.50M | -6.83M | -30.79M |
| Diluted EPS | - | -0.05 | -0.07 | - | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | -1.55M | 632.00K | 0 | 0 |
| Cost of Revenue | 7.28M | 3.95M | 0 | - | - |
| Gross Profit | 6.53M | -36.06M | 3.90M | - | - |
| Operating Expenses | - | 51.53M | 49.61M | 51.43M | 94.27M |
| Operating Income | - | -53.08M | -48.98M | -51.43M | -94.27M |
| EBITDA | - | -51.66M | -47.91M | -50.45M | -93.41M |
| Interest Expense | 0 | 1.30K | 101.85K | - | - |
| Pretax Income | - | -141.10M | -82.22M | -49.70M | -88.34M |
| Tax Provision | - | 103.00K | 0 | 0 | 0 |
| Net Income | - | -371.05M | -207.73M | -22.23M | -46.27M |
| Diluted EPS | -4.82 | -4.24 | -2.33 | -0.28 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 590.45M | 368.92M | 212.68M | 260.52M |
| Current Assets | - | 525.63M | 329.91M | 176.69M | 217.52M |
| Cash & Equivalents | - | 465.85M | 291.51M | 68.26M | 210.63M |
| Inventory | 4.27M | 0 | - | - | - |
| Receivables | 5.19M | 0 | - | - | - |
| Total Liabilities | - | 168.68M | 126.34M | 11.52M | 29.58M |
| Current Liabilities | - | 109.89M | 58.14M | 8.45M | 26.89M |
| Long Term Debt | - | - | 8.31M | - | - |
| Total Debt | - | 10.87M | 3.89M | 3.88M | 3.07M |
| Total Equity | - | 421.77M | 242.58M | 201.16M | 230.94M |
| Shares Outstanding | - | 190.88M | 194.07M | 196.33M | 270.74M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -49.58M | -72.70M | -52.67M | -20.60M |
| Investing Cash Flow | - | -5.18M | -15.16M | -136.01M | 104.97M |
| Financing Cash Flow | - | 3.91M | -8.24M | -335.00K | 57.73M |
| Capital Expenditure | - | -2.09M | -164.00K | -48.00K | -7.00K |
| Free Cash Flow | - | -51.67M | -72.86M | -52.72M | -20.60M |
| Net Change in Cash | - | -91.49M | -169.90M | -242.98M | 142.09M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 2,325.1% | 617.1% | - | - |
| Operating Margin % | - | 3,422.2% | -7,749.4% | - | - |
| Net Margin % | - | 23,923.5% | -32,868.5% | - | - |
| ROE % | - | -88.0% | -85.6% | -11.1% | -20.0% |
| ROCE % | - | -11.0% | -15.8% | -25.2% | -40.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NBP
Companies Like NovaBridge Biosciences (NASDAQ:NBP) Can Afford To Invest In Growth - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxPU0l6cVRIT1J6UEpZR2FudDlKT1paSkNoaGpwRE1WaF9ROU5uR3lTNFI2ejJkTlg1cXdBVGt4a1hLLXNMb1ZqRHNBOGxJLTRzUFpha0plSmxGNDlUazFyR3h3T0JqbzlmTXdtVjBzMFJZX3dTUlhKU1lOUHV5Qm9GRlVDYTVKUWdoaDFsVW…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE90dlQ0eGN1VWtFRFBfRnhzRHZ4aFhiaDdVdGk4Z2phel9VUWstRnBodzEwZEMyN0RuNFFtdHJ1QnNCWTA4dGFPc1hXbXk0V2c?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <font…
ADS Holders Must Use Citibank to Vote at NovaBridge AGM - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxOaVZuRXhqOXBHMFhMSGluYWZURUNYNFh6T29EWWJFNGdUYXBhNU55WkE1ZVZtZ1c0Y044S2tVNGIwcm5Ob2xqU1lHcWpJWHNiSWZ3NFlDMTNjVFJlLW9FYkx4TTNmS3hyb0wtQUU5WmZBUDR5WXhBcktfV3dyS2RvbW9ZcjlWYnkwekFTUz…
NBP Stock Price and Chart — NASDAQ:NBP - TradingView
<a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTFBYell5SGV2amd0YlhwUVYxcnVNR09FalY3SmNLUnV2NHFaVkJhbElRVUJYQ190V1JxMWtIWXVFdjQwSW9Bc0xVcmY0V1o1amtEdkktMWNHUzFYMHM?oc=5" target="_blank">NBP Stock Price and Chart — NASDAQ:NBP</a>&n…
NBP: NovaBridge Biosciences - Brokerage Recommendations Chart - Zacks Investment Research
<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE9icXVDUjEyRDh2VENUT0FHeUc3M3NNdDhtRkpYZ09oY2J2LV8zSnQyNWF5MXdua3EyWE1yVXZ0eVVWQXhoMGlIYzVEbmsxa2otZlFHdVBHakIzRjNnMHdaSHByNjFMODhLS3ZqaQ?oc=5" target="_blank">NBP: NovaBridge Biosc…
NovaBridge Biosciences (NASDAQ:NBP) Shares Could Be 41% Below Their Intrinsic Value Estimate - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi6wFBVV95cUxNT3gybjRKVUJ5ZTQtQ0tyVnJYNTRmTnNpOUJBZW5Da3c2RGZLbU4ycWhObVVTbGNPM3YzNnpUYmItbUhCZ3oxZTRGTHZnZTNwa3BQeE9qT2FyMWhCWkVUeG9uV1V2U3hZdVVMSzdVMlBEUThoZzF5SUVBNUY2dG01V3dCU3d4amNybG91WT…
NBP — Frequently Asked Questions
What is the current share price of NBP?
As of 2026-08-05 17:25 PDT, NBP trades at $1.64 on NASDAQ/NYSE. Its 52-week range is $1.47 to $6.56.
What is the market capitalisation of NBP?
NBP has a market capitalisation of $444.01M on NASDAQ/NYSE.
What is the P/E ratio of NBP?
NBP trades at a trailing price-to-earnings (P/E) ratio of -5.94. Its price-to-book (P/B) ratio is 1.92.
What is the return on equity (ROE) of NBP?
NBP has a return on equity (ROE) of -20.03%. Its return on capital employed (ROCE) is -40.35%.
Is NBP a good stock to buy?
This page provides a data-driven analysis of NBP, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.